Literature DB >> 4018106

Cimetidine pharmacokinetics and dosage requirements in children.

A Somogyi, M Becker, R Gugler.   

Abstract

The pharmacokinetics of cimetidine (10 mg/kg) were investigated in 11 children following an oral dose and in 9 children following an intravenous dose. The children ranged in age from 4-13 years and were undergoing radiology for upper gastrointestinal tract pain. Compared with a group of adults, the children had a higher total body clearance (11.6 +/- 3.4 versus 7.0 +/- 2.5 ml/min per kg; P less than 0.005), a larger apparent volume of distribution (1.24 +/- 0.40 versus 0.80 +/- 0.24 l/kg; P less than 0.005) and a shorter elimination half-life (83 +/- 26 versus 122 +/- 16 min; P less than 0.001) of cimetidine. Renal clearance in children comprised 70% of total body clearance, more than double that of adults (9.0 +/- 1.9 versus 4.2 +/- 2.1 ml/min per kg; P less than 0.001). The area under the cimetidine plasma concentration: time curve after the oral dose was on average 42% in children compared with adults. The mechanism for the increased elimination of cimetidine in children is suggested to be an increase in the renal tubular secretory transport of cimetidine in the kidney. A statistically significant negative correlation was observed between age and cimetidine renal clearance. A cimetidine dosage regimen of approximately 30 mg/kg per day in three to four divided doses would be an appropriate dose in children.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4018106     DOI: 10.1007/bf00491931

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  25 in total

1.  Glomerular filtration rate, effective renal blood flow, and maximal tubular excretory capacity in infancy.

Authors:  J R WEST; H W SMITH; H CHASIS
Journal:  J Pediatr       Date:  1948-01       Impact factor: 4.406

2.  Disappearance of phenobarbital and diphenylhydantoin from serum of children.

Authors:  L K Garrettson; P G Dayton
Journal:  Clin Pharmacol Ther       Date:  1970 Sep-Oct       Impact factor: 6.875

3.  Use of massive doses of procaineamide in the treatment of ventricular tachycardia in infancy.

Authors:  H Gelband; C N Steeg; J T Bigger
Journal:  Pediatrics       Date:  1971-07       Impact factor: 7.124

4.  Relationships between plasma theophylline clearance, liver volume and body weight in children and adults.

Authors:  J J Grygiel; H Ward; M Ogborne; A Goldin; D J Birkett
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Cimetidine use in children with cystic fibrosis: inhibition of hepatic drug metabolism.

Authors:  R A Bradbear; R W Shepherd; J Grice; J O'Toole; R K Roberts
Journal:  J Pediatr       Date:  1982-02       Impact factor: 4.406

6.  Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients.

Authors:  A Somogyi; H G Rohner; R Gugler
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

7.  The effect of cimetidine on maldigestion in cystic fibrosis.

Authors:  K L Cox; J N Isenberg; A B Osher; R R Dooley
Journal:  J Pediatr       Date:  1979-03       Impact factor: 4.406

8.  Zollinger-Ellison syndrome in a child: medical treatment with cimetidine.

Authors:  D P Drake; A G Maciver; J D Atwell
Journal:  Arch Dis Child       Date:  1980-03       Impact factor: 3.791

9.  Procainamide elimination kinetics in pediatric patients.

Authors:  S Singh; H Gelband; A V Mehta; K Kessler; A Casta; A S Pickoff
Journal:  Clin Pharmacol Ther       Date:  1982-11       Impact factor: 6.875

10.  [Semitransparent peroral small bowel imaging (author's transl)].

Authors:  D Emons
Journal:  Rofo       Date:  1981-10
View more
  7 in total

Review 1.  Dosage regimen of cimetidine reviewed. Possible drug accumulation after multiple oral doses.

Authors:  J Prandota; I J Smith; J T Wilson
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 2.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

Review 3.  Paediatric pharmacokinetics: key considerations.

Authors:  Hannah Katharine Batchelor; John Francis Marriott
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

4.  Alteration by burn injury of the pharmacokinetics and pharmacodynamics of cimetidine in children.

Authors:  J A Martyn; D J Greenblatt; J Hagen; D C Hoaglin
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Development and application of a pediatric mechanistic kidney model.

Authors:  Farzaneh Salem; Ben G Small; Trevor N Johnson
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-05-04

6.  Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults.

Authors:  Eva Fernandez; Raul Perez; Alfredo Hernandez; Pilar Tejada; Marta Arteta; Jose T Ramos
Journal:  Pharmaceutics       Date:  2011-02-07       Impact factor: 6.321

Review 7.  Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.

Authors:  Miriam G Mooij; Anne T Nies; Catherijne A J Knibbe; Elke Schaeffeler; Dick Tibboel; Matthias Schwab; Saskia N de Wildt
Journal:  Clin Pharmacokinet       Date:  2016-05       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.